ArticleTranslational pediatrics2026
Microcephaly, seizures and developmental delay caused by two novel mutations in the
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Microcephaly, seizures and developmental delay, known as MCSZ, is an uncommon autosomal recessive neurodevelopmental disorder linked to a bifunctional enzyme named polynucleotide-kinase-3'-phosphatase ( Case Description: We describe a patient with small anterior fontanelle and head circumference, refractory epilepsy and global developmental delay. He was a baby conceived via in vitro fertilization (IVF). Microcephaly and oligohydramnios were detected at 32 weeks. At 4 months, the patient had recurrent convulsions without fever, presenting with tonic-clonic seizures. He was treated with four anti-seizure medications (ASMs), but did not achieve satisfactory control. At the age of 5 years old, he had not learned to speak and was unable to stand unaided. The patient harbored two novel mutations, c. 1299-1G>A and c.1283_1287dup (p.S430Pfs*39), in the Conclusions: This is the third report of MCSZ in a non-consanguineous Chinese mainland family. Our results offer additional evidence for clinical variability associated with disorders stemming from mutations in the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.